New Test Promises to Clarify Unknown Cancer Diagnoses
The days of "Carcinoma of Unknown Primary Origin" diagnoses are coming to an end. The Food and Drug Administration has just announced clearance for marketing of a new genetic test, dubbed Pathwork Tissue of Origin test, from Pathwork Diagnostics , Inc., a Sunnyvale, CA firm. The test is based on a microarray technology to analyze thousands of...
